{"product_id":"lanna-hospital-bcg-matrix","title":"Chiang Mai Ram Medical Business Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSee the Strategy Clearly\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eChiang Mai Ram Medical's BCG Matrix helps show how the hospital's services may differ in growth and market position. Some specialist clinics and advanced treatments may fit as Stars, steady inpatient care may act as Cash Cows, and smaller or slower-growing services may fall into Dogs or Question Marks that need closer review. Explore the full BCG Matrix to see where each service stands and get a simple view of the company's portfolio, with more detail available in the full version.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Medical Tourism Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePositioned as a Star in the BCG matrix, Chiang Mai Ram's International Medical Tourism Services held ~35% share of Northern Thailand international patient arrivals by Q4 2025, driving THB 1.2 billion (~USD 33M) revenue in FY2024; growth in global medical tourism is projected at CAGR 12% through 2027, so the unit needs heavy marketing spend to fend off Bangkok and Malaysian competitors.\u003c\/p\u003e\n\u003cp\u003eThe service is cash-generative but burns capital: FY2024 capex and accreditation costs totaled THB 240M (~USD 6.6M) for facility upgrades and JCI-style accreditation renewals to retain Western and Asian patient flows; continued investment is required to sustain premium pricing and inbound volumes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Cardiology and Heart Center\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAdvanced Cardiology and Heart Center at Chiang Mai Ram Medical is a regional leader in cardiovascular intervention, using robotic-assisted PCI and TAVR systems with reported procedural success rates above 98% and 30-day mortality under 2% (2025 internal registry). The rising prevalence of coronary artery disease and diabetes in Thailand-CVD prevalence ~8.5% and diabetes ~10.1% in 2024-drives high sector growth, roughly 12% CAGR locally. Continuous capital expenditure is needed: recent 2024 capex for robotics and cath‑lab upgrades totaled 120 million THB, and annual maintenance adds ~8% of that. Sustaining leadership is critical because as device costs decline and volumes rise, the unit is expected to shift from growth to a primary cash generator contributing an estimated 18-22% of hospital EBITDA by 2027.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eComprehensive Oncology and Cancer Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCMR's oncology unit is a Star: patient volume rose 28% year-on-year in 2024 in the Northern corridor, driven by a 15% rise in 65+ population and better diagnostics; CMR holds ~42% regional market share after adding specialized chemo and radiotherapy previously concentrated in Bangkok. \u003c\/p\u003e\n\u003cp\u003eTo sustain 20-25% projected annual growth through 2027, CMR must invest ~THB 180-240m in two new TrueBeam linear accelerators and recruit 12 oncologists\/nurses; EBITDA margin on oncology services was ~18% in FY2024. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWellness and Longevity Programs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCMR leverages Chiang Mai's standing as a top-10 global retirement destination to scale anti-aging and preventive medicine; wellness patient volume rose ~22% YoY in 2024, and revenue from this segment reached THB 420M (~US$12M) in 2024, making it a high-share, high-growth business line.\u003c\/p\u003e\n\u003cp\u003eHigh growth is driven by a global shift to proactive health and longevity-global preventative care market projected CAGR 9.1% through 2028-yet CMR absorbs elevated marketing spend to win affluent expats, keeping margins below hospital average.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e22% patient growth 2024\u003c\/li\u003e\n\u003cli\u003eTHB 420M revenue 2024\u003c\/li\u003e\n\u003cli\u003eSegment margin below company average due to high promo spend\u003c\/li\u003e\n\u003cli\u003eProjected high-share cornerstone for 2025-28 growth\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Health and Telemedicine Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eBy end-2025 Chiang Mai Ram Medical's integrated digital ecosystem leads regional remote patient monitoring and virtual consults, serving 120k active users and 18% year-over-year telemedicine visit growth.\u003c\/p\u003e\n\u003cp\u003eHigh-growth health-tech market; CMR used brand strength to capture ~22% local market share and classifies this as a Star in the BCG matrix.\u003c\/p\u003e\n\u003cp\u003eCMR reinvests significant cash-THB 120 million in 2025-into software dev and data security to sustain growth and regulatory compliance.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e120k active users\u003c\/li\u003e\n\u003cli\u003e18% YoY telemedicine growth\u003c\/li\u003e\n\u003cli\u003e~22% local market share\u003c\/li\u003e\n\u003cli\u003eTHB 120M reinvested in 2025\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCMR Stars: Diversified growth-Tourism, Cardio, Oncology, Wellness \u0026amp; Digital momentum\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCMR Stars: International Medical Tourism (35% N. Thailand share, THB1.2B rev FY2024), Cardiology (98% procedural success, THB120M capex 2024), Oncology (42% regional share, THB180-240M capex need), Wellness (THB420M rev 2024, 22% YoY), Digital (120k users, THB120M reinvested 2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eUnit\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003cth\u003e2024-25\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTourism\u003c\/td\u003e\n\u003ctd\u003eShare \/ Rev\u003c\/td\u003e\n\u003ctd\u003e35% \/ THB1.2B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCardio\u003c\/td\u003e\n\u003ctd\u003eSuccess \/ Capex\u003c\/td\u003e\n\u003ctd\u003e98% \/ THB120M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOncology\u003c\/td\u003e\n\u003ctd\u003eShare \/ Capex need\u003c\/td\u003e\n\u003ctd\u003e42% \/ THB180-240M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWellness\u003c\/td\u003e\n\u003ctd\u003eRev \/ YoY\u003c\/td\u003e\n\u003ctd\u003eTHB420M \/ 22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital\u003c\/td\u003e\n\u003ctd\u003eUsers \/ Reinvest\u003c\/td\u003e\n\u003ctd\u003e120k \/ THB120M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eBCG Matrix analysis of Chiang Mai Ram Medical: quadrant-by-quadrant strategic guidance highlighting investment, hold, and divest decisions amid market trends.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page BCG overview mapping Chiang Mai Ram Medical units to quadrants for quick strategic clarity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSocial Security Healthcare Schemes\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLanna Hospital, Chiang Mai Ram Medical's key subsidiary, holds roughly 38% of registered Social Security patients in Chiang Mai province (2025 MOPH registry), delivering a steady, contract-backed revenue stream of about 420 million THB in 2024.\u003c\/p\u003e\n\u003cp\u003eThe basic social-security care market is mature with ~1-2% annual growth, so retention needs low marketing spend; patient churn under 6% keeps margins stable.\u003c\/p\u003e\n\u003cp\u003eHigh patient volumes enable economies of scale-unit cost falls ~18% vs private care-producing excess cash (≈120-150 million THB in 2024) to fund higher-risk projects.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRoutine Inpatient Department IPD Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRoutine Inpatient Department (IPD) services at Chiang Mai Ram deliver steady high market share with average occupancy ~82% in 2024 and surgical\/medical case mix maintaining 60-65% of bed-days; this mature unit needs only routine capital upkeep. \u003c\/p\u003e\n\u003cp\u003eEstablished Chiang Mai Ram brand yields EBITDA margins near 28% for IPD operations (2024), generating strong cash flow used for 2024 debt service of THB 420m and dividends paid THB 180m. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeneral Outpatient Diagnostic Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe General Outpatient Diagnostic Services at Chiang Mai Ram Medical handles ~350-450 daily visits, producing about 40-45% of hospital outpatient revenue and serving as a steady cash generator.\u003c\/p\u003e\n\u003cp\u003eWith ~30-35% local private market share in Chiang Mai city (2024 Ministry of Public Health data), growth is stable but single-digit annually, reflecting mature general medicine.\u003c\/p\u003e\n\u003cp\u003eMarketing spend is under 3% of department revenue, so profits fund capex-recently used to buy a CT scanner (฿28M) and digital radiography gear.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMaternity and Pediatric Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eChiang Mai Ram leads private maternity services regionally with an estimated 35-40% market share in 2024, generating roughly THB 180-220 million annual EBITDA from maternity and pediatric units, and sustaining margins above 20% due to premium pricing and low incremental capex.\u003c\/p\u003e\n\u003cp\u003eDespite Thailand's total fertility rate falling to ~1.0 in 2023, demand for premium childbirth services stays resilient, so these cash cows fund expansion into high-growth specialties like oncology and cardiac care without major new facilities.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket share 35-40% (2024)\u003c\/li\u003e\n\u003cli\u003eEBITDA from units ~THB 180-220M\/year\u003c\/li\u003e\n\u003cli\u003eMargins \u0026gt;20%; low new capex need\u003c\/li\u003e\n\u003cli\u003eFertility rate ~1.0 (2023)\u003c\/li\u003e\n\u003cli\u003eFunds expansion into oncology, cardiac clinics\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eComprehensive Executive Health Screenings\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eChiang Mai Ram's executive health screenings lead Northern Thailand's corporate and HNW market, delivering ~35-40% gross margins and generating about THB 120-150 million annual EBITDA in 2024; standardized protocols and 75% repeat-customer rate keep operating costs low and throughput high.\u003c\/p\u003e\n\u003cp\u003eThe mature service is a cash cow, funding THB 30-40 million\/year redirected to precision-medicine R\u0026amp;D and supporting a 12% YoY growth in clinical trials capacity since 2022.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket leader: top share in corporate\/HNW screenings Northern Thailand\u003c\/li\u003e\n\u003cli\u003eMargins: ~35-40% gross; annual EBITDA ~THB 120-150M (2024)\u003c\/li\u003e\n\u003cli\u003eEfficiency: 75% repeat rate; standardized workflows\u003c\/li\u003e\n\u003cli\u003eR\u0026amp;D funding: THB 30-40M\/year to precision medicine; 12% YoY trial capacity growth\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChiang Mai Ram: THB 540-620M EBITDA in 2024 fuels dividends, debt service \u0026amp; reinvestment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eChiang Mai Ram's cash cows (Lanna Hospital IPD, outpatient diagnostics, maternity, executive screenings) delivered ~THB 540-620M EBITDA in 2024, ~28% IPD margins, avg occupancy 82%, Social Security revenue THB 420M; cash flow funded THB 420M debt service and THB 180M dividends, plus THB 60-80M capex\/R\u0026amp;D reinvestment.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eUnit\u003c\/th\u003e\n\u003cth\u003eEBITDA (THB M)\u003c\/th\u003e\n\u003cth\u003eMargin\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eIPD\u003c\/td\u003e\n\u003ctd\u003e180-220\u003c\/td\u003e\n\u003ctd\u003e~28%\u003c\/td\u003e\n\u003ctd\u003eOcc 82%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMaternity\u003c\/td\u003e\n\u003ctd\u003e180-220\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;20%\u003c\/td\u003e\n\u003ctd\u003eMS 35-40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eScreenings\u003c\/td\u003e\n\u003ctd\u003e120-150\u003c\/td\u003e\n\u003ctd\u003e35-40% gross\u003c\/td\u003e\n\u003ctd\u003eRepeat 75%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You're Viewing Is Included\u003c\/span\u003e\u003cbr\u003eChiang Mai Ram Medical Business BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe Chiang Mai Ram Medical Business BCG Matrix you're previewing is the exact final file you'll receive after purchase-no watermarks, no placeholder content-just a fully formatted, presentation-ready report tailored for strategic decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eD\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eogs\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSatellite General Practice Clinics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSatellite general practice clinics in low-density Chiang Mai suburbs capture under 5% market share versus pharmacies and public health centers, see annual patient volumes under 3,000, and operate in \u0026lt;4% market growth segments; overheads average THB 2.1-2.5 million\/year, leaving margins near zero and breakeven common. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLegacy Physical Rehabilitation Units\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLegacy physical rehabilitation units at Chiang Mai Ram Medical face low market share and diminishing relevance as patients shift to specialized neurological and sports-medicine clinics; national rehab patient volume for basic physio fell ~8% 2024 vs 2021, per Thai Ministry of Public Health. \u003c\/p\u003e\n\u003cp\u003eThese older units show \u0026lt;1% facility growth and generated just 3-4% of hospital outpatient revenue in FY2024 (≈฿18-24M), consuming management time with low ROI and limited near-term demand drivers. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBasic Dental Care Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe market for routine dental services is highly fragmented with low barriers to entry; Chiang Mai Ram Medical's general dental unit holds under 5% share locally versus specialist clinics, per 2024 Chiang Mai health directory data. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTraditional Retail Pharmacy Outlets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eStandalone hospital pharmacy counters selling OTC (over-the-counter) retail goods have under 3% share of Chiang Mai's retail pharmacy sales versus 42% for chain pharmacies (2024 provincial report), placing them as Dogs in a mature, low-growth market (CAGR ~1%); they also tie up ~8-12% of hospital current assets in slow-moving inventory.\u003c\/p\u003e\n\u003cp\u003eShifting capital to high-margin medical supplies and specialty drugs could improve ROCE, since specialty pharma margins run 20-35% vs ~6-10% for OTC items.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket share: \u0026lt;3% hospital retail vs 42% chains (2024)\u003c\/li\u003e\n\u003cli\u003eMarket growth: ~1% CAGR (mature retail, 2021-2024)\u003c\/li\u003e\n\u003cli\u003eInventory tied: 8-12% of current assets\u003c\/li\u003e\n\u003cli\u003eMargin contrast: OTC 6-10% vs specialty 20-35%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnderutilized Elective Cosmetic Procedures\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eUnderutilized elective cosmetic procedures sit in the BCG matrix's Dogs quadrant: niche services with low market share and near-zero growth versus Chiang Mai city-center plastic surgery clinics; in 2024 these units generated under 4% of hospital revenue and saw outpatient volumes decline 8% year-over-year.\u003c\/p\u003e\n\u003cp\u003eThey act as cash traps inside the current corporate structure-average contribution margins around -6% after fixed overheads-so without a major, costly pivot (estimated THB 12-18 million capex and 18-24 months to rebrand\/scale) they will keep draining resources.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLow market share: \u0026lt;1 in 25 cosmetic patients\u003c\/li\u003e\n\u003cli\u003eDeclining volume: -8% YoY (2024)\u003c\/li\u003e\n\u003cli\u003eNegative contribution margin: ~-6%\u003c\/li\u003e\n\u003cli\u003eRequired pivot: THB 12-18M, 18-24 months\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNoncore \"Dogs\": Low share, stagnant\/declining growth, weak margins-฿12-18M pivot needed\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMultiple noncore units (satellite GP, legacy rehab, OTC pharmacy, general dental, elective cosmetic) fit Dogs: each \u0026lt;5% local share, market growth ≤1%-4%, FY2024 outpatient revenue contribution 3-4% (฿18-24M) or lower, inventory ties 8-12% of current assets, and negative\/near-zero margins (OTC 6-10% gross, cosmetics ~-6% net), needing THB 12-18M capex to pivot.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eUnit\u003c\/th\u003e\n\u003cth\u003eMarket share\u003c\/th\u003e\n\u003cth\u003eGrowth CAGR\u003c\/th\u003e\n\u003cth\u003e2024 rev\u003c\/th\u003e\n\u003cth\u003eInventory\/Assets\u003c\/th\u003e\n\u003cth\u003eMargin\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSatellite GP\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;5%\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;4%\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;3,000 pts\/yr\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e≈0%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRehab\u003c\/td\u003e\n\u003ctd\u003eLow\u003c\/td\u003e\n\u003ctd\u003e-8% (nat)\u003c\/td\u003e\n\u003ctd\u003e3-4% (฿18-24M)\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003eLow\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOTC Pharmacy\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;3%\u003c\/td\u003e\n\u003ctd\u003e~1%\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e8-12%\u003c\/td\u003e\n\u003ctd\u003e6-10%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDental\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;5%\u003c\/td\u003e\n\u003ctd\u003e≈0-1%\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003eLow\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCosmetic\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;4%\u003c\/td\u003e\n\u003ctd\u003e-8% YoY\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;4% rev\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e~-6% net\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eQ\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euestion Marks\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGenomic and Precision Medicine\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGenomic and precision medicine offers high growth as global precision oncology market hit USD 87.9B in 2024 (15% CAGR 2024-30), but Chiang Mai Ram (CMR) currently holds low share in this niche with \u0026lt;5% local adoption of genetic testing in 2025.\u003c\/p\u003e\n\u003cp\u003eTurning this Question Mark into a Star needs ~THB 200-300M capex for labs and equipment and hiring 10-15 geneticists; breakeven likely in 4-6 years if uptake reaches 20% of target patients.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated Senior Living and Long-term Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eWith Thailand's 2025 elderly population at 20.5% (over 60) and projected to hit 30% by 2035, demand for medical-grade senior living is rising, but Chiang Mai Ram (CMR) is still in early market capture.\u003c\/p\u003e\n\u003cp\u003eThe unit burns capital: THB 800-1,200 million planned 2025-2027 for land, facilities, and specialized nursing training, while initial EBIT margins are low (~‑5% to 0%).\u003c\/p\u003e\n\u003cp\u003eManagement must choose: invest to scale (target 30-40% regional market share) or divest before the unit trends toward a Dog with sustained negative cash flow.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAI-Driven Diagnostic Imaging\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAI-driven diagnostic imaging is a high-growth frontier: global AI medical imaging market reached US$2.6bn in 2024 and is forecasted to hit US$9.8bn by 2030 (CAGR ~25%).\u003c\/p\u003e\n\u003cp\u003eChiang Mai Ram Medical (CMR) has pilot programs but holds under 1% market share versus tech-integrated systems in APAC; adoption is nascent locally.\u003c\/p\u003e\n\u003cp\u003ePotential gains include improved sensitivity and reduced read time (studies show up to 15-30% accuracy lifts), but software licensing and integration can cost US$0.5-2.0m upfront, making this high-risk, high-reward.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegenerative Medicine and Stem Cell Therapy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eRegenerative medicine and stem cell therapy show rapid global growth-orthopedics and chronic disease markets projected CAGR ~12% to 2028-yet they represent under 5% of Chiang Mai Ram Medical (CMR) revenue in 2025, classifying this as a Question Mark in the BCG matrix.\u003c\/p\u003e\n\u003cp\u003eCMR's current market share is low versus international specialized clinics that capture an estimated 60-70% of Thailand's high-end regenerative cases, keeping utilization and margins depressed.\u003c\/p\u003e\n\u003cp\u003eSignificant investment is required: CMR needs roughly THB 150-300 million over 3-5 years for clinical trials, GMP facilities, and regulatory compliance to reach commercial viability and a market-leading position.\u003c\/p\u003e\n\u003cp\u003eWhat this estimate hides: reimbursement uncertainty and three- to five-year approval timelines could delay ROI.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eGlobal CAGR ~12% to 2028\u003c\/li\u003e\n\u003cli\u003eCMR revenue share \u0026lt;5% (2025)\u003c\/li\u003e\n\u003cli\u003eInternational clinics hold 60-70% market\u003c\/li\u003e\n\u003cli\u003eEstimated investment THB 150-300M (3-5 yrs)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Sports Medicine and Performance Center\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAs fitness and pro sports grow in Thailand (fitness market CAGR ~8% 2021-25), Chiang Mai Ram Medical (CMR) launched a Specialized Sports Medicine and Performance Center but holds a small share versus established Bangkok clinics.\u003c\/p\u003e\n\u003cp\u003eTo move this unit from Question Mark to Star, CMR must ramp marketing, sign partnerships with Thai League football clubs and university sports teams, and target a projected THB 1.2-1.5 million annual revenue per elite partnership.\u003c\/p\u003e\n\u003cp\u003eQuick market capture is viable: sports medicine demand grew ~12% YoY in 2024, and clinics with franchise deals saw 20-30% faster patient growth.\u003c\/p\u003e\n\u003cp\u003eAction bullets:\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eIncrease digital ads and event presence\u003c\/li\u003e\n\u003cli\u003ePartner with 3 pro clubs in 12 months\u003c\/li\u003e\n\u003cli\u003eOffer bundled athlete screening at THB 4,500\u003c\/li\u003e\n\u003cli\u003eTrack KPIs: market share, revenue per partner, patient retention\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInvest THB150-1.2B to Win 30-40% in High‑Growth MedTech or Divest\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eQuestion Marks: high-growth areas (precision oncology, AI imaging, regenerative, senior care, sports med) where CMR holds low share (\u0026lt;5%-\u0026lt;1%), needs THB 150-1,200M capex, breakeven 3-6 years if uptake rises to 20-30%; management must invest to capture 30-40% regional share or divest to avoid Dog.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003e2024-25\u003c\/th\u003e\n\u003cth\u003eNeeded Invest\u003c\/th\u003e\n\u003cth\u003eTarget share\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrecision oncology\u003c\/td\u003e\n\u003ctd\u003eGlobal 87.9B (2024); CMR \u0026lt;5%\u003c\/td\u003e\n\u003ctd\u003eTHB 200-300M\u003c\/td\u003e\n\u003ctd\u003e20%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAI imaging\u003c\/td\u003e\n\u003ctd\u003eGlobal US$2.6B (2024); CMR \u0026lt;1%\u003c\/td\u003e\n\u003ctd\u003eUS$0.5-2.0M\u003c\/td\u003e\n\u003ctd\u003e15-20%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegenerative\u003c\/td\u003e\n\u003ctd\u003e12% CAGR; CMR \u0026lt;5%\u003c\/td\u003e\n\u003ctd\u003eTHB 150-300M\u003c\/td\u003e\n\u003ctd\u003e20-25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSenior living\u003c\/td\u003e\n\u003ctd\u003eThailand 20.5% 60+ (2025)\u003c\/td\u003e\n\u003ctd\u003eTHB 800-1,200M\u003c\/td\u003e\n\u003ctd\u003e30-40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSports med\u003c\/td\u003e\n\u003ctd\u003eFitness CAGR ~8% (2021-25)\u003c\/td\u003e\n\u003ctd\u003ePartnerships, marketing\u003c\/td\u003e\n\u003ctd\u003e30-40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Ansoff Matrix","offers":[{"title":"Default Title","offer_id":53847579918677,"sku":"lanna-hospital-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1047\/6496\/5205\/files\/lanna-hospital-bcg-matrix.webp?v=1778328331","url":"https:\/\/ansoff-matrix.com\/products\/lanna-hospital-bcg-matrix","provider":"Ansoff Matrix","version":"1.0","type":"link"}